Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06324357
What this trial is testing

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Who this might be right for
Metastatic Breast CancerMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Boehringer Ingelheim 768
Not applicableStudy completedNCT04920669
What this trial is testing

Dexmedetomidine in Erector Spinae Block in Postoperative Analgesia

Who this might be right for
Postoperative Pain
Mohamed Elsayed Hassan 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04997941
What this trial is testing

Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients

Who this might be right for
Premenopausal Breast CancerHormone Receptor-positive Breast Cancer
Seoul National University Hospital 238
Not applicableStudy completedNCT07332754
What this trial is testing

Retrospective Observational Study on the Use of Advanced Bacterial-binding Dressings (DACC-coated Hydrogel Dressings) in Radiodermatitis

Who this might be right for
Radiodermatitis; Acute
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 18
Very early researchUnknownNCT02719795
What this trial is testing

Pectoral Nerves Blocks for Chronic Pain

Who this might be right for
Breast Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 140
Large-scale testing (Phase 3)Study completedNCT02019277
What this trial is testing

Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 50
Testing effectiveness (Phase 2)Ended earlyNCT01891357
What this trial is testing

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Who this might be right for
Carcinoma, Ductal, Breast
Women's Cancer Study Group GmbH 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05983094
What this trial is testing

Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer

Who this might be right for
Breast CancerNeoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 181
Not applicableStudy completedNCT04112966
What this trial is testing

Lymphedema Prevention in Breast Cancer

Who this might be right for
Breast CancerLymphedema
University of Castilla-La Mancha 150
Early research (Phase 1)Study completedNCT00128622
What this trial is testing

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
H. Kim Lyerly 24
Early research (Phase 1)UnknownNCT03076372
What this trial is testing

A Study Evaluating MM-310 in Patients With Solid Tumors

Who this might be right for
Solid TumorsUrothelial CarcinomaGastric Carcinoma+9 more
Merrimack Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT00066339
What this trial is testing

Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Not applicableStudy completedNCT02209857
What this trial is testing

The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy

Who this might be right for
BreastcancerInvasive Breast Carcinoma by Gene Expression Profile
Diakonessenhuis, Utrecht 660
Not applicableStudy completedNCT01428739
What this trial is testing

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Who this might be right for
Breast Cancer
AHS Cancer Control Alberta 8
Early research (Phase 1)Study completedNCT03502395
What this trial is testing

Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion

Who this might be right for
Cancer, Breast
Assiut University 80
Not applicableEnded earlyNCT02483377
What this trial is testing

Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer

Who this might be right for
Breast Carcinoma
University of Southern California 13
Not applicableUnknownNCT04034953
What this trial is testing

Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong

Who this might be right for
ObesityColorectal CancerProstate Cancer+1 more
Chinese University of Hong Kong 10,000
Large-scale testing (Phase 3)Study completedNCT01275677
What this trial is testing

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Who this might be right for
HER2/Neu PositiveProgesterone Receptor PositiveRecurrent Breast Carcinoma+6 more
National Cancer Institute (NCI) 3,270
Testing effectiveness (Phase 2)UnknownNCT01625429
What this trial is testing

Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Cancer Hospital, China 30
Early research (Phase 1)Study completedNCT03739931
What this trial is testing

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Who this might be right for
Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or LymphomaDose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma
ModernaTX, Inc. 134
Next Page